140 related articles for article (PubMed ID: 21464157)
21. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Rotnakkarin P; Sutcharitchan P; Wannagrairoj P
Clin Lymphoma; 2003 Jun; 4(1):52-5. PubMed ID: 12837156
[TBL] [Abstract][Full Text] [Related]
23. Treatment, patterns of failure, and survival of patients with Stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the Comprehensive Cancer Centre West.
Krol AD; Hermans J; Dawson L; Snijder S; Wijermans PW; Kluin-Nelemans HC; Kluin PM; van Krieken JH; Noordijk EM
Cancer; 1998 Oct; 83(8):1612-9. PubMed ID: 9781956
[TBL] [Abstract][Full Text] [Related]
24. Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists.
Naresh KN; Agarwal B; Nathwani BN; Diebold J; McLennan KA; Muller-Hermelink KH; Armitage JO; Weisenburger DD
Leuk Lymphoma; 2004 Aug; 45(8):1569-77. PubMed ID: 15370208
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
[TBL] [Abstract][Full Text] [Related]
26. Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study.
Ekberg S; E Smedby K; Glimelius I; Nilsson-Ehle H; Goldkuhl C; Lewerin C; Jerkeman M; Eloranta S
Br J Haematol; 2020 Jun; 189(6):1083-1092. PubMed ID: 32065396
[TBL] [Abstract][Full Text] [Related]
27. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China.
Wang C; Xia B; Ning Q; Zhao H; Yang H; Zhao Z; Wang X; Wang Y; Yu Y; Zhang Y
Ann Hematol; 2018 Mar; 97(3):453-457. PubMed ID: 29188315
[TBL] [Abstract][Full Text] [Related]
29. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
[TBL] [Abstract][Full Text] [Related]
30. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
[TBL] [Abstract][Full Text] [Related]
31. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
32. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
33. Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.
Porcu P; Nichols CR
Curr Probl Cancer; 1998; 22(5):283-368. PubMed ID: 9869020
[TBL] [Abstract][Full Text] [Related]
34. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence.
Cleghorn FR; Manns A; Falk R; Hartge P; Hanchard B; Jack N; Williams E; Jaffe E; White F; Bartholomew C
J Natl Cancer Inst; 1995 Jul; 87(13):1009-14. PubMed ID: 7629870
[TBL] [Abstract][Full Text] [Related]
35. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.
Naresh KN; Srinivas V; Soman CS
Ann Oncol; 2000; 11 Suppl 1():63-7. PubMed ID: 10707782
[TBL] [Abstract][Full Text] [Related]
36. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
[TBL] [Abstract][Full Text] [Related]
37. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.
Coté TR; Biggar RJ; Rosenberg PS; Devesa SS; Percy C; Yellin FJ; Lemp G; Hardy C; Geodert JJ; Blattner WA
Int J Cancer; 1997 Nov; 73(5):645-50. PubMed ID: 9398040
[TBL] [Abstract][Full Text] [Related]
38. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
39. Incidence and survival of gastric non-Hodgkin's lymphoma: a population-based study from the Association of the French Cancer Registries (FRANCIM).
Danzon A; Belot A; Maynadié M; Remontet L; Dupont AC; Carbonnel F;
Acta Oncol; 2009; 48(7):977-83. PubMed ID: 19551530
[TBL] [Abstract][Full Text] [Related]
40. Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017.
Sun H; Xue L; Guo Y; Du J; Nan K; Li M
Ann Med; 2022 Dec; 54(1):633-645. PubMed ID: 35196922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
